Stein Gold, L.; Bagel, J.; Tyring, S. K.; Hong, C.- ho; Pavlovsky, L.; Pinter, A.; Reich, A.; Drogaris, L.; Wu, T.; Photowala, H.; Stakias, V. .; Richter, S.; Papp, K. Efficacy and Safety of Risankizumab Compared With Apremilast in Patients With Moderate Plaque Psoriasis: Mean PASI and BSA Results From the Phase 4 IMMpulse Trial. J of Skin 2023, 7, s257.